VERTEX PHARMACEUTICALS INC / MA (VRTX) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$12.0B

Net Income/Loss (FY2025)

$4.0B

Total Assets (FY2025)

$25.6B

Total Equity (FY2025)

$18.7B

Cash Flows from Operating Activities (FY2025)

$3.6B

Source: VERTEX PHARMACEUTICALS INC / MA 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.